GENE ONLINE|News &
Opinion
Blog

AstraZenca
Weekly Cover: Expansion of Samsung Biologics Projects into U.S. and Europe
2020-02-11
Weekly in Asia|Dec-3
2020-01-02
Weekly in Asia|Dec-1
2019-12-17
Astra Zeneca to Resume Rivalry with Old Competitor Following Key Win for FASENRA®
2019-10-14
Weekly in Asia | SEP-1
2019-09-17
Weekly in Asia 2019|AUG-3
2019-08-25
Lynparza Meets Primary Endpoint in Phase III PROfound Trial
2019-08-16
BIO Asia Taiwan Review: The AI Tide, How Informatics Shape the Future of Pharmaceutical Industry
2019-08-12
First PARP inhibitor approved for 1L maintenance therapy of BRCAm advanced ovarian cancer
2018-12-28
Fruquintinib becomes the first homegrown oncology drug approved in China for major indication
2018-09-11
PARP inhibitors in cancer – BRCA or no BRCA
2018-07-03
1 3 4 5
LATEST
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top